- Home
- VRAX vs ADN Comparison
VRAX vs ADN Comparison
Compare VRAX & ADN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRAX
- ADN
- Stock Information
- Founded
- VRAX 2013
- ADN 2006
- Country
- VRAX United Kingdom
- ADN United States
- Employees
- VRAX N/A
- ADN N/A
- Industry
- VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- ADN Power Generation
- Sector
- VRAX Health Care
- ADN Utilities
- Exchange
- VRAX Nasdaq
- ADN Nasdaq
- Market Cap
- VRAX 4.4M
- ADN 4.9M
- IPO Year
- VRAX 2022
- ADN N/A
- Fundamental
- Price
- VRAX $0.75
- ADN $4.55
- Analyst Decision
- VRAX Strong Buy
- ADN
- Analyst Count
- VRAX 1
- ADN 0
- Target Price
- VRAX $3.00
- ADN N/A
- AVG Volume (30 Days)
- VRAX 132.3K
- ADN 2.1M
- Earning Date
- VRAX 01-01-0001
- ADN 08-12-2025
- Dividend Yield
- VRAX N/A
- ADN N/A
- EPS Growth
- VRAX N/A
- ADN N/A
- EPS
- VRAX N/A
- ADN N/A
- Revenue
- VRAX $6,331.00
- ADN $115,000.00
- Revenue This Year
- VRAX $217,274.83
- ADN $6,528.51
- Revenue Next Year
- VRAX N/A
- ADN N/A
- P/E Ratio
- VRAX N/A
- ADN N/A
- Revenue Growth
- VRAX N/A
- ADN N/A
- 52 Week Low
- VRAX $0.72
- ADN $1.71
- 52 Week High
- VRAX $9.00
- ADN $8.79
- Technical
- Relative Strength Index (RSI)
- VRAX 38.90
- ADN 79.07
- Support Level
- VRAX $0.72
- ADN $1.85
- Resistance Level
- VRAX $0.80
- ADN $1.95
- Average True Range (ATR)
- VRAX 0.07
- ADN 0.52
- MACD
- VRAX -0.01
- ADN 0.22
- Stochastic Oscillator
- VRAX 10.07
- ADN 46.61
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes (HSV-1) and Human Papillomavirus (HPV).
About ADN Advent Technologies Holdings Inc.
Advent Technologies Holdings Inc is an innovation-driven company in the fuel cell and hydrogen technology space, including liquid hydrogen carriers such as methanol. The company develops, manufactures, and assembles complete fuel cell systems and the critical components that determine the performance of hydrogen fuel cells and other energy systems. It serves automotive; aviation and power generation industries. It generates revenue from the sale of fuel cell systems and the sale of MEAs, membranes, and electrodes for specific applications in the fuel cell and energy storage (flow battery) markets.